# The FAVOR II China Study

> **NCT03191708** · — · COMPLETED · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 308 (actual)

## Conditions studied

- Coronary Artery Disease
- Myocardial Ischemia
- Cardiovascular Diseases
- Arteriosclerosis
- Coronary Disease
- Arterial Occlusive Diseases
- Heart Diseases
- Vascular Diseases

## Interventions

- **DIAGNOSTIC_TEST:** Fractional Flow Reserve (FFR)

## Key facts

- **NCT ID:** NCT03191708
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-13
- **Primary completion:** 2017-07-20
- **Final completion:** 2017-07-20
- **Target enrollment:** 308 (ACTUAL)
- **Last updated:** 2017-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03191708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03191708, "The FAVOR II China Study". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03191708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*